PoliorixTM

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Poliomyelitis

Phase 3

Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers

CompletedNCT00920439

GlaxoSmithKlinePoliomyelitis

Start: 2009-06-01End: 2009-08-03Updated: 2018-01-19

Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers

CompletedNCT01323647

GlaxoSmithKlinePoliomyelitis

Start: 2011-04-25End: 2011-09-19Updated: 2019-02-11

Related Papers

Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.

2016-02-0911 citations